Početna › Rak mjehura › Missouri
Kliničke studije za Rak mjehura u državi Missouri
27 studija za Rak mjehura traži sudionike na lokacijama u državi Missouri.
Gradovi u državi Missouri
- St. Louis22 studija
- Kansas City10 studija
- Cape Girardeau5 studija
- Columbia4 studija
- Springfield4 studija
- Saint Joseph4 studija
- O'Fallon3 studija
- Lee's Summit3 studija
Službeni tekst studije (engleski)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Washington University School of Medicine in St. Louis, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
- Central Care Cancer Center - Bolivar, Bolivar
- Cox Cancer Center Branson, Branson
- i još 21
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Saint Francis Medical Center, Cape Girardeau
- Parkland Health Center - Farmington, Farmington
- University of Kansas Cancer Center - Briarcliff, Kansas City
- i još 8
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06770582A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- University of Missouri Health Care ( Site 0126), Columbia
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06833073A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Washington University, School of Medicine, St Louis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Saint Francis Medical Center, Cape Girardeau
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07061964Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Missouri Cancer Associates, Columbia
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Saint Francis Medical Center, Cape Girardeau
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- i još 11
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Siteman Cancer Center - St. Peters, City of Saint Peters
- Siteman Cancer Center - West County, Creve Coeur
- Siteman Cancer Center - North County, Florissant
- i još 4
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07421700A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Oncology Hematology Associates, Springfield
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07218380Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT06529822Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Washington University, St Louis
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT05267626Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Specialty Clinical Research of St. Louis, St Louis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06567743Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Washington University School of Medicine, St Louis
U tijeku regrutacijaOpažajna studija
Od 18 do 50 godina · Žene · Ažurirano 2. ruj 2026. · NCT06904365The Vanguard Study: Testing a New Way to Screen for Cancer
- Saint Luke's Hospital of Kansas City, Kansas City
- Washington University School of Medicine, St Louis
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 45 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT06995898Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Renown Regional Medical Center, St Louis
- Specialty Clinic Research of St. Louis, St Louis
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Renown Regional Medical Center, St Louis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 21. kol 2026. · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Washington University in St. Louis, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05614739Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Central Care Cancer Center - Bolivar, Bolivar
- Mercy Cancer Center - Cape Girardeau, Cape Girardeau
- Saint Francis Medical Center, Cape Girardeau
- i još 19
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07097142IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT06910657A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph
U tijeku regrutacijaFaza 2
Od 8 godina i više · Oba spola · Ažurirano 27. srp 2026. · NCT05503797An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Kansas City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT07720284Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- i još 3
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - SPG, Springfield
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT07327489Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
- Washington University, St Louis
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. tra 2026. · NCT05982561Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Washington University, St Louis
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 18. velj 2026. · NCT07030257SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.